Coronavirus

>

Latest News

Study: COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone
Study: COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone

April 22nd 2024

Researchers found that the COVID-19 booster dose elicited a 71%-84% increase in the median anti-spike half-life over that of the primary series.

RSV Disease Severity Comparable to Unvaccinated COVID-19, Flu: Daily Dose / image credit: ©New Africa/AdobeStock
RSV Disease Severity Comparable to Unvaccinated COVID-19, Flu: Daily Dose

April 18th 2024

RSV Disease Severity Comparable to Unvaccinated COVID-19, Influenza: New Research / image credit older man in hospital ©auremar/stock.adobe.com
RSV Disease Severity Comparable to Unvaccinated COVID-19, Influenza: New Research

April 11th 2024

COVID-19 Vaccines Reduce Risk of Cardiac, Thromboembolic Outcomes: Daily Dose / image credit: ©New Africa/AdobeStock
COVID-19 Vaccines Reduce Risk of Cardiac, Thromboembolic Outcomes: Daily Dose

March 27th 2024

Moderna Next-Gen mRNA COVID-19 Vaccine Meets Primary Endpoints in NextCOVE Phase 3 Trial / image credit Moderna logo: ©desertsands/stock.adobe.com
Moderna Next-Gen mRNA COVID-19 Vaccine Meets Primary Endpoints in NextCOVE Phase 3 Trial

March 27th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.